Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
- 2020 WS
Vergangene Veranstaltungen (max. 10)
- 2020 SS
- 2019 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapyIn: Journal of Cancer Research and Clinical Oncology Jg. 147 (2021) Nr. 2, S. 579 - 591
ISSN: 1432-1335; 0171-5216Online Volltext: dx.doi.org/ (Open Access) -
Duktales Adenokarzinom des Pankreas : Entstehung, Diagnostik, TherapieIn: Der Gastroenterologe Jg. 16 (2021) Nr. 1, S. 41 - 50
ISSN: 1861-969X; 1861-9681Online Volltext: dx.doi.org/ -
Early dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC) : A post hoc analysis of NAPOLI-1In: Pancreatology Jg. 21 (2021) Nr. 1, S. 192 - 199
ISSN: 1424-3911; 1424-3903Online Volltext: dx.doi.org/ (Open Access) -
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113) : a multicentre, randomised, phase 2 trialIn: The Lancet Gastroenterology & Hepatology Jg. 6 (2021) Nr. 2, S. 128 - 138
ISSN: 2468-1253Online Volltext: dx.doi.org/ -
The Latest Developments in Imaging of Fibroblast Activation ProteinIn: Journal of Nuclear Medicine Jg. 62 (2021) Nr. 2, S. 160 - 167
ISSN: 2159-662X; 0161-5505Online Volltext: dx.doi.org/ -
The predictive and prognostic significance of cell-free DNA concentration in melanomaIn: Journal of the European Academy of Dermatology and Venereology (JEADV) Jg. 35 (2021) Nr. 2, S. 387 - 395
ISSN: 1468-3083; 0926-9959Online Volltext: dx.doi.org/ (Open Access) -
Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemiaIn: Therapeutic Advances in Hematology Jg. 11 (2020) S. 1 - 15
ISSN: 2040-6207; 2040-6215Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodelingIn: Journal of Nuclear Cardiology (2020)
ISSN: 1532-6551; 1071-3581Online Volltext: dx.doi.org/ (Open Access) -
Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinomaIn: International Journal of Cancer: publication of the International Union against Cancer (UICC) = Journal international du cancer Jg. 147 (2020) Nr. 10, S. 2847 - 2861
ISSN: 1097-0215; 0020-7136Online Volltext: dx.doi.org/ (Open Access) -
Duktales Adenokarzinom des Pankreas : Entstehung, Diagnostik, TherapieIn: Der Onkologe Jg. 26 (2020) Nr. 10, S. 977 - 985
ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/ -
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerIn: Cell Death and Disease Jg. 11 (2020) Nr. 10, S. 875
ISSN: 2041-4889Online Volltext: dx.doi.org/ (Open Access) -
Image-Based Molecular Phenotyping of Pancreatic Ductal AdenocarcinomaIn: Journal of Clinical Medicine Jg. 9 (2020) Nr. 3, S. 724
ISSN: 2077-0383Online Volltext: dx.doi.org/ (Open Access) -
Implementing cell-free DNA of pancreatic cancer patient–derived organoids for personalized oncologyIn: JCI Insight Jg. 5 (2020) Nr. 15, S. e137809
ISSN: 2379-3708Online Volltext: dx.doi.org/ (Open Access) -
Lactate Dehydrogenase Prior to Transarterial Hepatic Chemoperfusion Predicts Survival and Time to Progression in Patients with Uveal Melanoma Liver MetastasesIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren (2020) in press
ISSN: 1438-9010; 1438-9029Online Volltext: dx.doi.org/ -
Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer : Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 TrialIn: Pancreas Jg. 49 (2020) Nr. 1, S. 62 - 75
ISSN: 1536-4828; 0885-3177Online Volltext: dx.doi.org/ (Open Access) -
Loss of Wasl improves pancreatic cancer outcomeIn: JCI Insight Jg. 5 (2020) Nr. 10,
ISSN: 2379-3708Online Volltext: dx.doi.org/ (Open Access) -
Mir34a constrains pancreatic carcinogenesisIn: Scientific Reports Jg. 10 (2020) Nr. 1, S. 9654
ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access) -
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastomaIn: Scientific Reports Jg. 10 (2020) Nr. 1, S. 7157
ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access) -
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC)In: International Journal of Cancer Jg. 147 (2020) Nr. 9, S. 2493 - 2502
ISSN: 1097-0215; 0020-7136Online Volltext: dx.doi.org/ (Open Access) -
Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancerIn: Cancers Jg. 12 (2020) Nr. 2, S. 353
ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Proton Irradiation Increases the Necessity for Homologous Recombination Repair Along with the Indispensability of Non-Homologous End JoiningIn: Cells Jg. 9 (2020) Nr. 4, S. 889
ISSN: 2073-4409Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 TrialIn: Clinical Chemistry Jg. 66 (2020) Nr. 12, S. 1510 - 1520
ISSN: 0009-9147; 1530-8561Online Volltext: dx.doi.org/ -
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancerIn: Cell Death Discovery Jg. 6 (2020) Nr. 1, S. 12
ISSN: 2058-7716Online Volltext: dx.doi.org/ (Open Access) -
The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulationIn: International Journal of Cancer: IJC Jg. 147 (2020) Nr. 1, S. 189 - 201
ISSN: 1097-0215; 0020-7136Online Volltext: dx.doi.org/ (Open Access) -
Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinomaIn: Oncogene Jg. 39 (2020) Nr. 24, S. 4770 - 4779
ISSN: 1476-5594; 0950-9232Online Volltext: dx.doi.org/ (Open Access) -
A Novel Approach for Image-Guided I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene DeliveryIn: Molecular Cancer Research Jg. 17 (2019) Nr. 1, S. 310 - 320
ISSN: 1541-7786; 1557-3125Online Volltext: dx.doi.org/ -
A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapyIn: PLoS ONE Jg. 14 (2019) Nr. 10, S. e0218642
ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access) -
A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imagingIn: European Radiology Experimental Jg. 3 (2019) Nr. 1, S. 41
ISSN: 2509-9280Online Volltext: dx.doi.org/ (Open Access) -
Covalent-Allosteric Inhibitors to Achieve Akt Isoform-SelectivityIn: Angewandte Chemie International Edition Jg. 58 (2019) Nr. 52, S. 18823 - 18829
ISSN: 1433-7851; 1521-3773Online Volltext: dx.doi.org/ (Open Access) -
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer : a subgroup analysis of the pivotal NAPOLI-1 trialIn: Journal of Geriatric Oncology Jg. 10 (2019) Nr. 3, S. 427 - 435
ISSN: 1879-4076; 1879-4068Online Volltext: dx.doi.org/ (Open Access) -
MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In VivoIn: Stem Cells International Jg. 2019 (2019) S. 8475389
ISSN: 1687-966X; 1687-9678Online Volltext: dx.doi.org/ (Open Access) -
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer : Final overall survival analysis and characteristics of long-term survivorsIn: European Journal of Cancer Jg. 108 (2019) S. 78 - 87
ISSN: 0959-8049; 1879-0852; 1879-2995Online Volltext: dx.doi.org/ (Open Access) -
Neurotrophic tropomyosin receptor kinase (NTRK) and nerve growth factor (NGF) are not expressed in Caucasian patients with biliary tract cancers : pooled data from three independent cohortsIn: Clinical and Translational Oncology Jg. 21 (2019) Nr. 8, S. 1108 - 1111
ISSN: 1699-048X; 1699-3055Online Volltext: dx.doi.org/ -
Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic CancerIn: Cancers Jg. 11 (2019) Nr. 8, S. 1068
Online Volltext: dx.doi.org/ (Open Access) -
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal CancerIn: Cancer Research Jg. 79 (2019) Nr. 9, S. 2367 - 2378
ISSN: 0008-5472; 1538-7445; 0099-7013; 0099-7374Online Volltext: dx.doi.org/ -
Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorinIn: European Journal of Cancer Jg. 106 (2019) S. 24 - 33
ISSN: 0959-8049; 1879-0852Online Volltext: dx.doi.org/ (Open Access) -
Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma CellsIn: The Journal of Investigative Dermatology Jg. 139 (2019) Nr. 12, S. 2506 - 2516.e10
ISSN: 1523-1747; 0022-202XOnline Volltext: dx.doi.org/ -
18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancerIn: OncoTarget Jg. 9 (2018) Nr. 11, S. 10128 - 10134
ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access) -
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable diseaseIn: The Lancet Oncology Jg. 19 (2018) Nr. 3, S. e151 - e160
ISSN: 1470-2045; 1474-5488Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Decreased appetite (DA) at baseline impacts prognosis in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC)In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 5, S. v42 - v43
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access) -
Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX : A prospective phase II study of the ‘Arbeitsgemeinschaft Internistische Onkologie’In: European Journal of Cancer Jg. 94 (2018) S. 95 - 103
ISSN: 1879-2995; 0959-8049Online Volltext: dx.doi.org/ -
Epigenetics of gastrointestinal diseases : notes from a workshopIn: Epigenetics Jg. 13 (2018) Nr. 4, S. 449 - 457
ISSN: 1559-2308; 1559-2294Online Volltext: dx.doi.org/ -
Fibroblast-activating protein : Targeting the roots of the tumor microenvironmentIn: Journal of Nuclear Medicine Jg. 59 (2018) Nr. 9, S. 1412 - 1414
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ -
Immunotherapy and Combination Strategies in Pancreatic Cancer : Current Status and Emerging TrendsIn: Oncology Research and Treatment Jg. 41 (2018) Nr. 5, S. 286 - 290
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Impact of dose reduction or dose delay on the efficacy of liposomal irinotecan (nal-IRI)+5-fluorouracil/leucovorin (5-FU/LV) : Survival analysis from NAPOLI-1In: Annals of Oncology: official journal of the European Society for Medical Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii250 - viii251
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access) -
NAPOLI-1 phase III trial outcomes by prior surgery, and disease stage, in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)In: Annals of Oncology: official journal of the European Society for Medical Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii249 - viii250
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access) -
Notch-induced myeloid reprogramming in spontaneous pancreatic ductal adenocarcinoma by dual genetic targetingIn: Cancer Research Jg. 78 (2018) Nr. 17, S. 4997 - 5010
ISSN: 0008-5472; 1538-7445Online Volltext: dx.doi.org/ -
PAXgene fixation enables comprehensive metabolomic and proteomic analyses of tissue specimens by MALDI MSIIn: Biochimica et Biophysica Acta (BBA) - General Subjects Jg. 1862 (2018) Nr. 1, S. 51 - 60
ISSN: 0304-4165; 1872-8006Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
PICCA study : panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker-driven clinical phase II AIO studyIn: European Journal of Cancer Jg. 92 (2018) S. 11 - 19
ISSN: 1879-2995; 0959-8049Online Volltext: dx.doi.org/ -
Prognostic value of baseline biliary stents on outcomes in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the NAPOLI-1 trialIn: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 5, S. v42
ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ (Open Access) -
Secondary resectability in locally advanced pancreatic cancer (LAPC) after nab-paclitaxel/gemcitabine- versus FOLFIRINOX-based induction chemotherapy : Interim results of a randomized phase II AIO trial (NEOLAP)In: Journal of Clinical Oncology: JCO; official journal of the American Society of Clinical Oncology Jg. 36 (2018) Nr. 4_suppl, S. 348 - 348
ISSN: 1527-7755; 0732-183XOnline Volltext: dx.doi.org/ -
Subgroup analysis by baseline (BL) weight-associated parameters : A phase III study of liposomal irinotecan (nal-IRI)+/--5fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gIn: Journal of Clinical Oncology Jg. 36 (2018) Nr. Suppl. 4, S. 410
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Subgroup analysis by baseline pain intensity (BPI) and analgesic use (BAU) in NAPOLI-1 : A phase III study of liposomal irinotecan (nal IRI)+/- 5-fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) pIn: Journal of Clinical Oncology Jg. 36 (2018) Nr. Suppl. 4, S. 379
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Subgroup analysis by measurable metastatic lesion (ML) number and selected lesion locations (LL) at baseline (BL) in NAPOLI-1 : A phase III study of liposomal irinotecan (nal-IRI)+/- 5-fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic panIn: Journal of Clinical Oncology Jg. 36 (2018) Nr. Suppl. 4, S. 460
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1 : Expanded analysis of a global phase 3 trialIn: European Journal of Cancer Jg. 105 (2018) S. 71 - 78
ISSN: 0959-8049Online Volltext: dx.doi.org/ (Open Access) -
The effect of best response to prior anticancer therapy on efficacy outcomes in the NAPOLI-1 trial of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapyIn: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 5, S. v42
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access) -
Apparent Diffusion Coefficient (ADC) predicts therapy response in pancreatic ductal adenocarcinomaIn: Scientific Reports Jg. 7 (2017) 10.1038/s41598-017-16826-z
ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access) -
CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-1601)In: Annals of Oncology Jg. 28 5 (2017) -
ISSN: 0923-7534; 1569-8041 -
Co-clinical assessment of tumor cellularity in pancreatic cancerIn: Clinical Cancer Research Jg. 23 (2017) Nr. 6, S. 1461 - 1470
ISSN: 1557-3265; 1078-0432Online Volltext: dx.doi.org/ -
Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic PlasticityIn: Gastroenterology Jg. 152 (2017) Nr. 6, S. 1507 - 1520.e15
ISSN: 1528-0012; 0016-5085Online Volltext: dx.doi.org/ (Open Access) -
Epigenetic treatment of pancreatic cancer : Is there a therapeutic perspective on the horizon?In: Gut Jg. 66 (2017) Nr. 1, S. 168 - 179
ISSN: 1468-3288; 0017-5749Online Volltext: dx.doi.org/ (Open Access) -
Extended RAS analysis and correlation with overall survival in advanced pancreatic cancerIn: The British Journal of Cancer: BJC Jg. 116 (2017) Nr. 11, S. 1462 - 1469
ISSN: 1532-1827; 0007-0920Online Volltext: dx.doi.org/ (Open Access) -
Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4-and MYC-dependent mannerIn: Nucleic Acids Research Jg. 45 (2017) Nr. 11, S. 6334 - 6349
ISSN: 1362-4962; 0301-5610; 0305-1048Online Volltext: dx.doi.org/ (Open Access) -
Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) geneIn: OncoTarget Jg. 8 (2017) Nr. 20, S. 33393 - 33404
ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access) -
Integrin-Targeted Hybrid Fluorescence Molecular Tomography/X-ray Computed Tomography for Imaging Tumor Progression and Early Response in Non-Small Cell Lung CancerIn: Neoplasia: An International Journal for Oncology Research Jg. 19 (2017) Nr. 1, S. 8 - 16
ISSN: 1476-5586; 1522-8002Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitisIn: PLoS ONE Jg. 12 (2017) Nr. 12, S. e0190074
ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access) -
Oncogenic KRas-induced Increase in Fluid-phase Endocytosis is Dependent on N-WASP and is Required for the Formation of Pancreatic Preneoplastic LesionsIn: EBioMedicine Jg. 15 (2017) S. 90 - 99
ISSN: 2352-3964Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Prognostic value of baseline neutrophil-to-lymphocyte ratio for predicting clinical outcome in metastatic pancreatic ductal adenocarcinoma (mPDAC) patients treated with liposomal irinotecan (nal-IRI)+5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alonIn: Ann Oncol Jg. 28 5 (2017) -
ISSN: 0923-7534; 1569-8041 -
Quality-adjusted survival with combination nal-IRIFU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy : a Q-TWiST analysisIn: The British Journal of Cancer: BJC Jg. 116 (2017) Nr. 10, S. 1247 - 1253
ISSN: 1532-1827; 0007-0920Online Volltext: dx.doi.org/ (Open Access) -
Final results of NAPOLI-1 : A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapyIn: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 622PD
ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ -
Gemcitabine impairs tumor perfusion in stroma rich murine endogenous PDACIn: European Journal of Cancer Jg. 69 (2016) Nr. Suppl. 1, S. S67 - S68
ISSN: 0959-8049Online Volltext: dx.doi.org/ -
Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse ModelIn: American Journal of Pathology Jg. 186 (2016) Nr. 11, S. 2934 - 2944
ISSN: 0002-9440; 1525-2191Online Volltext: dx.doi.org/ -
Identification of metabolic changes in Pancreatic Ductal AdenocarcinomaIn: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 76 - 77
ISSN: 2296-5270 -
Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cellsIn: Oncogene Jg. 35 (2016) Nr. 29, S. 3880 - 3886
ISSN: 0950-9232; 1476-5594Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Membranous CD24 drives the epithelial phenotype of pancreatic cancerIn: Oncotarget Jg. 7 (2016) Nr. 31, S. 49156 - 49168
ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access) -
Modeling therapy response and spatial tissue distribution of erlotinib in pancreatic cancerIn: Molecular Cancer Therapeutics Jg. 15 (2016) Nr. 5, S. 1145 - 1152
ISSN: 1538-8514; 1535-7163Online Volltext: dx.doi.org/ (Open Access) -
Next-generation metabolic imaging in pancreatic cancerIn: Gut Jg. 65 (2016) Nr. 3, S. 367 - 369
ISSN: 0017-5749Online Volltext: dx.doi.org/ -
RAC1 activity is necessary for the development of murine undifferentiated PDACIn: Eur J Cancer Jg. 69 (2016) Nr. Suppl. 1, S. 140
ISSN: 0959-8049Online Volltext: dx.doi.org/ -
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER studyIn: Journal of Hepatology Jg. 65 (2016) Nr. 2, S. 280 - 288
ISSN: 0168-8278Online Volltext: dx.doi.org/ -
Time course of selected treatment emergent adverse events (TEAEs) in NAPOLI-1 : A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapyIn: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, S. 693P
ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ -
γ-Secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targetsIn: OncoTarget Jg. 7 (2016) Nr. 39, S. 62799 - 62813
ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access) -
PERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer : a translational subgroup analysis from AIO-PK0104In: BMC Cancer Jg. 14 (2014) Nr. 1, S. 624
ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access) -
Phosphorylated ERK (pERK) as biomarker in patients with advanced pancreatic cancer treated with erlotinib within a randomized phase III trial (AIO-PK0104)In: Journal of Clinical Oncology Jg. 31 (2013) Nr. 4 Suppl., S. 189
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Resminostat in advanced hepatocellular carcinoma (HCC) : Overall survival subgroup analysis of prognostic factors in the SHELTER trialIn: Journal of Clinical Oncology Jg. 31 (2013) Nr. 15 Suppl., S. e15088
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
S3-Leitlinie zum exokrinen PankreaskarzinomIn: Zeitschrift für Gastroenterologie Jg. 51 (2013) Nr. 12, S. 1395 - 1440
ISSN: 1439-7803Online Volltext: dx.doi.org/ -
EGF Receptor Is Required for KRAS-Induced Pancreatic TumorigenesisIn: Cancer Cell Jg. 22 (2012) Nr. 3, S. 304 - 317
ISSN: 1535-6108; 1878-3686Online Volltext: dx.doi.org/ (Open Access) -
MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancerIn: PLoS ONE Jg. 7 (2012) Nr. 6, S. e39424
ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access) -
An inducible Tet-Off-H2B-GFP lentiviral reporter vector for detection and in vivo isolation of label-retaining cellsIn: Experimental Cell Research Jg. 316 (2010) Nr. 11, S. 1885 - 1895
ISSN: 1090-2422; 0014-4827Online Volltext: dx.doi.org/ -
Identification of epidermal pdx1 expression discloses different roles of notch1 and notch2 in murine krasG¹²D-induced skin carcinogenesis in vivoIn: PLoS ONE Jg. 5 (2010) Nr. 10, S. e13578
ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access) -
Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinomaIn: Proceedings of the National Academy of Sciences of the United States of America Jg. 107 (2010) Nr. 30, S. 13438 - 13443
ISSN: 1091-6490; 0027-8424Online Volltext: dx.doi.org/ (Open Access) -
Pancreatic cancer transcriptomes : molecular stratification in the adjuvant settingIn: Annals of Oncology Jg. 32 (2021) Nr. 2, S. 133 - 135
ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ -
Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic : Are There Any Concerns?In: Journal of Nuclear Medicine: JNM Jg. 61 (2020) Nr. 8, S. 1094 - 1095
ISSN: 1535-5667; 2159-662X; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Growth factor independence 1 expression induced metabolic vulnerabilities and presents novel therapeutic opportunities in acute myeloid leukemia
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 43 - 44
ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Interim safety analysis of the phase IIb study of ramucirumab in combination with TAS102 vs. TAS102 monotherapy in metastatic colorectal cancer : The RAMTAS trial of the German AIOIn: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S427 - S428
ISSN: 0923-7534Online Volltext: dx.doi.org/ -
A phase IIb study of ramucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic, chemotherapy refractory colorectal cancer patients : The RAMTAS trial of the German AIO (KRK-0316)In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. TPS3617 - TPS3617
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Clinical relevance of comprehensive genomic analysis in advanced-stage cancers and rare malignancies : Results from the MASTER trial of the German Cancer ConsortiumIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 13,
ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ -
PET-directed combined modality therapy for gastroesophageal junction cancer : First results of the prospective MEMORI trialIn: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. 4018 - 4018
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Advanced organoid culture technology in pancreatic cancer and its translational applications
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 206
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT-PMO-1601)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 156
ISSN: 2296-5270; 2296-5262Online Volltext: dx.doi.org/ -
Metabolic heterogeneity as a PET-biomarker predicts overall survival of pancreatic cancer patientsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 97
ISSN: 1619-7089Online Volltext: dx.doi.org/ -
Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancer
30th EORTC – NCI – AACR Symposium; 13 Nov - 16 Nov 2018; Dublin, Ireland,In: European Journal of Cancer Jg. 103 (2018) Nr. Supplement 1, S. E101
ISSN: 1879-0852; 0959-8049Online Volltext: dx.doi.org/ -
Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancerIn: Cancer Research Jg. 78 (2018) Nr. Suppl. 13,
ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ -
Prognostic effect of primary tumor location in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC)In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 5, S. v41 - v42
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access) -
The prognostic value of the modified glasgow prognostic score (mGPS) in predicting overall survival (OS) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) receiving liposomal irinotecan (nal-IRI)+5-fluorouracil and leucovorin (5-FU/LV)In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii255 - viii256
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access) -
Co-clinical assessment of tumor cellularity in pancreatic cancerIn: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 175
ISSN: 2296-5270Online Volltext: dx.doi.org/ -
Effects of nanoliposomal irinotecan (nal-IRI;MM-398) +/- 5-Fluorouracil and leucavorin (5-FU/LV) on quality of life (QoL) in NAPOLI-1 : a phase 3 study in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) previously treated with gemcitabine-bIn: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 259
ISSN: 2296-5270Online Volltext: dx.doi.org/ -
Expanded analyses of NAPOLI-1 : Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based theIn: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 170
ISSN: 2296-5270Online Volltext: dx.doi.org/ -
Patient-derived organoids to model intra- and intertumoral heterogeneity of pancreatic cancer in high-throughput drug screensIn: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 162
ISSN: 2296-5270Online Volltext: dx.doi.org/ -
Quality-adjusted time without symptoms or toxicity (Q-TWIST) of nanoliposomal irinotecan (nal-IRI;MM-398) plus 5-fluorouracil and leucavorin (5-FU/LV) vs 5-FU/LV alone in patients with metastatic pancreatic adenocarcinoma (mPAC) previously treated with geIn: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 260
ISSN: 2296-5270Online Volltext: dx.doi.org/ -
Targeting notch for myeloid reprogramming in pancreatic cancerIn: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 16
ISSN: 2296-5270Online Volltext: dx.doi.org/ -
Use of Diffusion-weighted magnetic resonance imaging for therapy response evaluation in pancreatic cancerIn: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 113 - 114
ISSN: 2296-5270Online Volltext: dx.doi.org/ -
Na-Folfiri plus sunitinib versus Na-Folfiri alone in advanced chemorefractory esophagogastric cancer patients : A randomized double-blinded placebo-controlled multicentric AIO phase II trial
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 74
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Clinical update on the phase I/II trial of HDAC inhibitor resminostat in patients with sorafenib-resistant hepatocellular carcinoma (HCC) - The Shelter Study
13th World Congress on Gastrointestinal Cancer 22–25 June 2011, Barcelona, Spain,In: Annals of Oncology Jg. 22 (2011) Nr. Suppl. 5, S. v76 - v76
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ -
Correlation of molecular profiles with response to targeted drugs in pancreatic cancer modelsIn: European Journal of Cancer Jg. 138, Supplement 2 (2020) S. S58 - S59
ISSN: 1879-0852; 0959-8049Online Volltext: dx.doi.org/ (Open Access)